Clinical Evaluation of the Mandibular Mini-Implant Overdenture
1 other identifier
observational
80
1 country
1
Brief Summary
Stabilization of existing full lower dentures by means of mini-dental implants (MDI). To test whether 4 mini-implants placed at the front of the lower jaw can stabilize an immediately-modified existing lower denture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 5, 2010
CompletedFirst Posted
Study publicly available on registry
February 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedDecember 2, 2024
November 1, 2024
4.1 years
February 5, 2010
November 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success rate of mandibular overdentures supported by 4 MDIs placed in the interforaminal region in the long term.
3 years
Secondary Outcomes (1)
Oral health-related quality of life and general satisfaction of patients.
3 years
Study Arms (1)
4 Imtec mini-dental implants (MDI)
4 Imtec MDI
Interventions
Eligibility Criteria
Dental implant
You may qualify if:
- Completely edentulous with last tooth extraction 2 years ago or longer.
- Patients requesting implant stabilization of existing lower conventional denture.
- Adequate space in anterior mandible for placement of 4 MDI implants.
- Able to maintain adequate oral hygiene and keep dentures clean.
- Healthy enough to have minor surgical procedures.
- Have adequate understanding of written and spoken English or French.
- Capable of providing written informed consent.
You may not qualify if:
- Not enough room in mandibular bone for implant height.
- Has acute or chronic symptoms of parafunctional disorders.
- History of radiotherapy to orofacial region.
- Are or have been taking bisphosphonate IV or other medications (to be evaluated by the researcher).
- Health conditions that may jeopardize treatment (to be evaluated by the researcher).
- Unable or unwilling to return for evaluations or study recalls.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Solventum US LLClead
- McGill Universitycollaborator
- 3Mcollaborator
Study Sites (1)
Faculty of Dentistry, McGill University
Montreal, Quebec, H3A 2A7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jocelyne Feine, DDS, MSc, HDR
Professor, Principal Investigator
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2010
First Posted
February 9, 2010
Study Start
February 1, 2010
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
December 2, 2024
Record last verified: 2024-11